Sergi Fernandez-Gonzalez, Catalina Falo, Maria J Pla, Miriam Campos, Carlos Ortega-Exposito, Raul Ortega, Maria Vicente, Ana Petit, Jan Bosch-Schips, Maria Teresa Bajen, Gabriel Reyes, Evelyn Martínez, Javier González-Viguera, Judith Peñafiel, Agostina Stradella, Sonia Pernas, Jordi Ponce, Amparo Garcia-Tejedor
PURPOSE: In patients with clinically lymph node-negative (cN0) breast cancer, performing sentinel lymph node biopsy (SLNB) after neoadjuvant chemotherapy (NACT) has been preferentially embraced in comparison to before NACT. However, survival outcomes associated with both strategies remain understudied. We aimed to compare the axillary lymphadenectomy (ALND) rate, disease-free survival (DFS), and overall survival (OS), between two strategies. METHODS: We included 310 patients in a retrospective observational study...
April 18, 2024: Breast Cancer Research and Treatment